PASSAGE BIO, INC. Other Current Liabilities
PASSAGE BIO, INC. (PASG) had Other Current Liabilities of $2.00 million as of 2024-03-31, per its 10-Q filed 2024-05-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2025-03-04
- 2024-03-31: Other Liabilities, Current $2.00M.
- 2023-12-31: Other Liabilities, Current $2.00M.
- 2023-09-30: Other Liabilities, Current $4.00M.
- 2023-06-30: Other Liabilities, Current $5.00M.
| Period end | Other Liabilities, Current |
|---|---|
| 2024-03-31 | $2.00M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $2.00M 10-K · filed 2025-03-04 |
| 2023-09-30 | $4.00M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $5.00M 10-Q · filed 2023-08-07 |
| 2023-03-31 | $4.00M 10-Q · filed 2023-05-11 |
| 2022-09-30 | $571.00K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $1.14M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $2.12M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $500.00K 10-K · filed 2023-03-06 |
| 2021-03-31 | $2.00M 10-Q · filed 2021-05-05 |
| 2020-12-31 | $541.00K 10-K · filed 2022-03-03 |
| 2020-09-30 | $169.00K 10-Q · filed 2020-11-10 |
| 2020-06-30 | $65.00K 10-Q · filed 2020-08-13 |
| 2020-03-31 | $18.00K 10-Q · filed 2020-05-11 |
| 2019-12-31 | $46.00K 10-K · filed 2021-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |